Korean pharmaceutical company GC Biopharma has announced it has applied for approval of its GC1109 recombinant anthrax vaccine to the Korean Ministry of Food and Drug Safety.
According to GC Biophrama “GC1109 contains protective antigen (PA) as its active pharmaceutical ingredients produced by recombinant DNA technology which delivers 2 types of proteins that comprise anthrax toxin, namely, lethal factor (LF) and edema factor (EF), into cells.”
GC Biopharma in a press release revealed the reason they’re creating the vaccine is “in order to prepare against potential bioterrorism.”
If approved the ‘GC1109’ will be the world’s first recombinant anthrax vaccine. GC #Biopharma has applied for the approval of #GC1109 , potentially the world’s first recombinant #anthrax #vaccine , which has shown promising safety and efficacy in Phase II trials. #anthraxvaccine https://t.co/V9uJ0QzxZk — Health and Pharma (@HealthNDPharma) November 6, 2023 Per Yahoo Finance : GC Biopharma announced 1 Nov. 2023 that it has applied […]
Read the Whole Article From the Source: www.thegatewaypundit.com
It’s becoming increasingly clear that fiat currencies across the globe, including the U.S. Dollar, are under attack. Paper money is losing its value, translating into insane inflation and less value in our life’s savings.
Genesis Gold Group believes physical precious metals are an amazing option for those seeking to move their wealth or retirement to higher ground. Whether Central Bank Digital Currencies replace current fiat currencies or not, precious metals are poised to retain or even increase in value. This is why central banks and mega-asset managers like BlackRock are moving much of their holdings to precious metals.
As a Christian company, Genesis Gold Group has maintained a perfect 5 out of 5 rating with the Better Business Bureau. Their faith-driven values allow them to help Americans protect their life’s savings without the gimmicks used by most precious metals companies. Reach out to them today to see how they can streamline the rollover or transfer of your current and previous retirement accounts.
